Neuroprotective and symptomatological action of memantine relevant for alzheimer's disease - a unified glutamatergic hypothesis on the mechanism of action

被引:185
作者
Danysz, Wojciech [1 ]
Parsons, Chris G. [1 ]
Moebius, Hans-Joerg [1 ]
Stoeffler, Albrecht [1 ]
Quack, Guenter [1 ]
机构
[1] Merz Co, Dept Pharmacol, Eckenheimer Landstr 100-104, D-60318 Frankfurt, Germany
关键词
NMDA receptors; Memantine; Alzheimer's disease; Dementia; Neuroprotection; Hypothesis;
D O I
10.1007/BF03033787
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The involvement of glutamate mediated neurotoxicity in the pathogenesis of Alzheimer's disease is finding increasingly more acceptance in the scientific community. Central to this hypothesis is the assumption that in particular glutamate receptors of the N-methyl-D-aspartate (NMDA) type are overactivated in a tonic rather than a phasic manner. Such continuous mild activation leads under chronic conditions to neuronal damage. Moreover, one should consider that impairment of plasticity (learning) may result not only from neuronal damage per se but also from continuous activation of NMDA receptors. To investigate this possibility we tested whether over-activation of NMDA receptors using either non-toxic doses/concentrations of a direct NMDA agonist or through an indirect approach - decrease in magnesium concentration o produces deficits in plasticity. In fact NMDA bothin vivo (passive avoidance test) andin vitro (LTP in CA1 region) impaired learning and synaptic plasticity. Under these conditions mem-antine which is an uncompetitive NMDA receptor antagonists with features of "improved magnesium" (voltage dependence, affinity) attenuated the deficit. The more direct proof that memantine can act as a surrogate for magnesium was obtained in LTP experiments under low magnesium conditions. In this case as well, impaired LTP was restored in the presence of therapeutically relevant concentrations of memantine (1 mu M).In vivo, doses leading to similar brain/serum levels produce neuroprotection in animal models relevant for neurodegeneration in Alzheimer's disease such as neurotoxicity produced by inflammation in the NBM or beta -amyloid injection to the hippocampus. Hence, we postulate that if in Alzheimer's disease overactivation of NMDA receptors occurs indeed, memantine would be expected to improve both symptoms (cognition) and slow down disease progression because it takes over the physiological function of magnesium.
引用
收藏
页码:85 / 97
页数:13
相关论文
共 65 条
[11]   Modifications of neuronal phosphorylated tau immunoreactivity induced by NMDA toxicity [J].
Couratier, P ;
Lesort, M ;
Sindou, P ;
Esclaire, F ;
Yardin, C ;
Hugon, J .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1996, 27 (03) :259-273
[12]   Effects of beta-amyloid-(25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: Evidence for a selective affinity for the glutamate and glycine recognition sites of the NMDA receptor [J].
Cowburn, RF ;
Wiehager, B ;
Trief, E ;
LiLi, M ;
Sundstrom, E .
NEUROCHEMICAL RESEARCH, 1997, 22 (12) :1437-1442
[13]   beta-amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus [J].
Cullen, WK ;
Wu, JQ ;
Anwyl, R ;
Rowan, MJ .
NEUROREPORT, 1996, 8 (01) :87-92
[14]  
DANYSZ W, 1995, BEHAV PHARMACOL, V6, P455
[15]   Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - Preclinical studies [J].
Danysz, W ;
Parsons, CG ;
Kornhuber, J ;
Schmidt, WJ ;
Quack, G .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (04) :455-468
[16]  
DITZLER K, 1991, ARZNEIMITTEL-FORSCH, V41-2, P773
[17]   CORTICAL PYRAMIDAL NEURON LOSS MAY CAUSE GLUTAMATERGIC HYPOACTIVITY AND COGNITIVE IMPAIRMENT IN ALZHEIMERS-DISEASE - INVESTIGATIVE AND THERAPEUTIC PERSPECTIVES [J].
FRANCIS, PT ;
SIMS, NR ;
PROCTER, AW ;
BOWEN, DM .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (05) :1589-1604
[18]   Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices [J].
Frankiewicz, T ;
Potier, B ;
Bashir, ZI ;
Collingridge, GL ;
Parsons, CG .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (04) :689-697
[19]   Differential effects of NMDA-receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices [J].
Frankiewicz, T ;
Pilc, A ;
Parsons, CG .
NEUROPHARMACOLOGY, 2000, 39 (04) :631-642
[20]   Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices [J].
Frankiewicz, T ;
Parsons, CG .
NEUROPHARMACOLOGY, 1999, 38 (09) :1253-1259